Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Mercy

 

This 3D medical animation describes the process of a HIPEC procedure, including Cytoreductive Surgery.

Dr. Armando Sardi of Surgical Oncology at Mercy Medical Center in Baltimore, Maryland, is widely regarded for his training and skills in utilizing Hyperthermic intraperitoneal chemotherapy (HIPEC) to treat advanced stages of abdominal cancer (peritoneal surface malignancies). Dr. Sardi and an experienced team of oncologists work with a specialized clinical team at Mercy to perform this procedure with a high level of expertise for patients facing a diagnosis of peritoneal cancer.

What is Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a heated chemotherapy solution that is used in conjunction with cytoreductive surgery. Cytoreductive surgery is performed first to remove visible tumors from the abdominal area. 

Following the surgery, heated chemotherapy solution is added to the abdominal cavity to destroy non-visible or microscopic tumor cells that may remain after surgery. Heat helps kill the cancer cells and also enhances the effect of chemotherapy. 

NEXT: How is Hyperthermic Intraperitoneal Chemotherapy (HIPEC) performed? ›
How is Hyperthermic Intraperitoneal Chemotherapy (HIPEC) performed?

Following the cytoreductive surgery, several tubes are inserted in the abdominal cavity. The abdominal cavity is then flooded with the heated chemotherapy solution and the solution is pumped throughout for approximately 90 minutes. This method allows the heated chemotherapy to reach all surfaces of the abdominal cavity and treat the microscopic cancer cells that could potentially form new cancerous tumors. 

NEXT: Who should receive Hyperthermic Intraperitoneal Chemotherapy (HIPEC)? ›
Who should receive Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Used in conjunction with cytoreductive surgery, HIPEC can improve survival and quality of life for patients who would have limited hope for a solution to their advanced cancer.

NEXT: Why have Hyperthermic Intraperitoneal Chemotherapy (HIPEC) performed at Mercy? ›
Why have Hyperthermic Intraperitoneal Chemotherapy (HIPEC) performed at Mercy?

Mercy’s cancer surgeons and their clinical team are recognized nationally as leaders in aggressive cytoreductive surgery and HIPEC. Due to the complexity of the combined therapies, surgeons must be appropriately trained and experienced to offer these treatment methods.

The Surgical Oncology team at Mercy in Baltimore performs these procedures on a frequent basis and offers a high level of expertise to patients facing a diagnosis of peritoneal cancer.

NEXT: Patient Stories ›
Patient Stories
Surgical Oncology at Mercy - Baltimore

Ellene

A patient is treated at Mercy for a nearly-fatal disease - she recalls her experience with Mercy's "unfailingly kind" doctors, staff and healthcare team.

Surgical Oncology at Mercy

Helen

A Mercy patient says she believes in miracles after being diagnosed with primary peritoneal cancer and given a second chance at life.

Surgical Oncology at Mercy - Baltimore

Georgy

Fate brings together Mercy's Dr. Gushchin and a Russian teenager in desperate need of advanced cancer treatment.

Meet Our Doctors: Surgical Oncology
Dr. Armando Sardi
Armando Sardi, M.D.

A 2016 TOP DOC
Dr. Armando Sardi is a respected and renowned cancer surgeon as well as the Medical Director of The Institute for Cancer Care at Mercy and as Chief of Surgical Oncology at Mercy.

See all Surgical Oncologists ›
Patient Story: Colorectal Cancer
Patient receives treatment at Surgical Oncology at Mercy in Baltimore
Willie

Hear the inspiring story of a man who survived colon cancer, liver cancer and a liver transplant - treated by a team doctors at Mercy.

See All Stories Like This ›